Wuhan Sian Medical Technology Co., Ltd
4 clinical trials · Sponsor
◉ Watch Wuhan Sian Medical Technology Co., Ltd
| Record | Firm | Date |
|---|---|---|
| Humanized CD19 Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy in Treating Patients With B-cell Malignancies (NCT04008251) | Wuhan Sian Medical Technology Co., Ltd | 2019-05-27 |
Track Wuhan Sian Medical Technology Co., Ltd automatically
Every clearance here is in the API, with alerts when new ones post.